Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
4,416 pregnant women with asthma were included in a population-based retrospective cohort study using Taiwan's National Health Insurance Research Database and Birth Certification Application from 2010 to 2022. The study, authored by Chun-Tse Hung and last updated in 2026, compared fetal outcomes between 16 omalizumab users and 4,410 inhaled corticosteroid users. It found no statistically significant increased risk of adverse fetal outcomes associated with omalizumab use.
Dataset size is 116.5 KB, indicating a very limited scope, likely containing summary results or documentation rather than the full underlying patient-level data.